Brookfield Corp’s NEVRO CORP. NVRO Stock Holding History

Brookfield Corp’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,014	Closed	-$397K	–	808
2022 Q4	$397K	Buy	+10,014	New	+$416K	﹤0.01%	550
2022 Q3	–	Sell	-7,605	Closed	-$333K	–	792
2022 Q2	$333K	Sell	7,605 -768	-9%	-$42.2K	﹤0.01%	549
2022 Q1	$606K	Buy	8,373 +3,127	+60%	+$225K	﹤0.01%	541
2021 Q4	$425K	Buy	5,246 +266	+5%	+$26.7K	﹤0.01%	550
2021 Q3	$580K	Sell	4,980 -4,705	-49%	-$616K	﹤0.01%	468
2021 Q2	$1.61M	Buy	9,685 +3,760	+63%	+$587K	0.01%	395
2021 Q1	$827K	Buy	+5,925	New	+$967K	﹤0.01%	386

Other funds holding NVRO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brookfield Corp's NVRO Position: Q1 2023 in Review

Brookfield Corp sold out of NEVRO CORP. (NVRO) in Q1 2023, closing a stake of 10,014 shares — an estimated $397K sold.

Brookfield Corp first reported a position in NVRO in Q1 2021 and held it in 7 quarters. The position peaked at $1.61M in Q2 2021. 158 funds tracked by Wall St. Rank hold NVRO as of Q1 2023.

Brookfield Corp reported no remaining NEVRO CORP. position as of Q1 2023 after selling out during the quarter.
Brookfield Corp sold 10,014 NEVRO CORP. shares in Q1 2023, an estimated $397K.
Brookfield Corp first reported a position in NEVRO CORP. in Q1 2021 and held it in 7 quarters.
Brookfield Corp's NEVRO CORP. position peaked at $1.61M in Q2 2021.
158 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2023.

Based on Brookfield Corp's 13F filing for Q1 2023, filed 15 May 2023.